Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciclesonide + formoterol vs fluticasone + salmeterol in persistent asthma
2004-002983-80Phase 2Completed
- Sponsor
- Altana Pharma
- Start
- Nov 2004
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of ciclesonide, formoterol, fluticasone propionate and salmeterol in asthma (2 arms), sponsored by Altana Pharma. Primary endpoint: Primary efficacy outcome. Started Nov 2004; status: completed.
02
Drugs
ciclesonideformoterolfluticasone propionatesalmeterol
03
Conditions
asthma
Beyond the preview
Go deeper on 2004-002983-80.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002983-80.